Subcutaneous methotrexate in patients with moderate-to-severe psoriasis: a critical appraisal.

Tsakok, T; Jabbar-Lopez, Z K; Smith, C H

Tsakok, T; Jabbar-Lopez, Z K; Smith, C H.

Tsakok T; St John's Institute of Dermatology, King's College London and Guy's and St Thomas' NHS Foundation Trust, Great Maze Pond, London, SE1 9RT, U.K.
Jabbar-Lopez ZK; St John's Institute of Dermatology, King's College London and Guy's and St Thomas' NHS Foundation Trust, Great Maze Pond, London, SE1 9RT, U.K.
Smith CH; St John's Institute of Dermatology, King's College London and Guy's and St Thomas' NHS Foundation Trust, Great Maze Pond, London, SE1 9RT, U.K.

Br J Dermatol ; 179(1): 50-53, 2018 07.

Article en En | MEDLINE | ID: mdl-29399784

Asunto(s)

Metotrexato; Psoriasis; Adulto; Método Doble Ciego; Francia; Alemania; Humanos; Masculino; Persona de Mediana Edad; Países Bajos; Estudios Prospectivos; Resultado del Tratamiento

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Psoriasis / Metotrexato Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adult / Humans / Male / Middle aged País como asunto: Europa Idioma: En Año: 2018 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google